287 related articles for article (PubMed ID: 20807810)
1. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
Tauler J; Zudaire E; Liu H; Shih J; Mulshine JL
Cancer Res; 2010 Sep; 70(18):7137-47. PubMed ID: 20807810
[TBL] [Abstract][Full Text] [Related]
2. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
3. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y
Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition.
Choi HS; Lee HM; Jang YJ; Kim CH; Ryu CJ
Stem Cells; 2013 Dec; 31(12):2647-58. PubMed ID: 23495120
[TBL] [Abstract][Full Text] [Related]
6. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Zhou J; Nong L; Wloch M; Cantor A; Mulshine JL; Tockman MS
Lung Cancer; 2001 Dec; 34(3):341-50. PubMed ID: 11714531
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
8. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
10. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
13. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer.
Gu W; Liu W; Shen X; Shi Y; Wang L; Liu H
Ann Diagn Pathol; 2013 Feb; 17(1):14-7. PubMed ID: 22622045
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
15. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
18. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer.
Pino I; Pío R; Toledo G; Zabalegui N; Vicent S; Rey N; Lozano MD; Torre W; García-Foncillas J; Montuenga LM
Lung Cancer; 2003 Aug; 41(2):131-43. PubMed ID: 12871776
[TBL] [Abstract][Full Text] [Related]
19. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation.
He Y; Brown MA; Rothnagel JA; Saunders NA; Smith R
J Cell Sci; 2005 Jul; 118(Pt 14):3173-83. PubMed ID: 16014382
[TBL] [Abstract][Full Text] [Related]
20. [RNA interference of hnRNP B1 gene in human A549 lung cells].
Pu D; Zhou TY; Li WM; Wu D; Chen XB; Chen M; Tang FM; Han J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):805-7. PubMed ID: 19024319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
